7 completed. 6 Phase 1, 1 Phase 2.
By phase and status
Follow BMS-986166: new trials by email Literature Review of BMS-986166 trials Research Report on BMS-986166
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants
BMS-986166, Bisacodyl - Healthy Participants | Phase 1 | Completed | Bristol-Myers Squibb | 7 | 2022-06-17 | 2023-03-22 |
A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis
BMS-986166, Branebrutinib, Placebo - Dermatitis, Atopic | Phase 2 | Completed | Bristol-Myers Squibb | 17 | 2021-08-17 | 2023-10-18 |
A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential
BMS-986166, Oral contraceptive - Healthy Participants | Phase 1 | Completed | Bristol-Myers Squibb | 25 | 2021-08-03 | 2022-03-18 |
A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants
BMS-986166, Itraconazole, Extended Phenytoin Sodium - Healthy Participants | Phase 1 | Completed | Bristol-Myers Squibb | 15 | 2021-07-28 | 2022-05-13 |
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants
BMS-986166, Placebo - Healthy Volunteers | Phase 1 | Completed | Bristol-Myers Squibb | 23 | 2021-07-15 | 2022-03-09 |
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers
BMS-986166, Placebo matching BMS-986166 - Ulcerative Colitis | Phase 1 | Completed | Bristol-Myers Squibb | 213 | 2017-02-01 | 2019-01-30 |
A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
BMS-986166, Placebo matching BMS-986166 - Healthy | Phase 1 | Completed | Bristol-Myers Squibb | 66 | 2016-07-28 | 2017-11-24 |
Conditions studied
Colitis, Ulcerative (1) · Dermatitis, Atopic (1)
Sponsors
Bristol-Myers Squibb (7)
Countries
United States (7) · Australia (1) · Austria (1) · Canada (1) · Germany (1) · Poland (1) · Spain (1)
Results publications
PMID 32306792